Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 1

Status

Completed 5

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Genitourinary 1CNS 1

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 640Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 454Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 372Dexamethasone 351Doxorubicin 328Nivolumab 308Fluorouracil 286Capecitabine 260Prednisone 244Etoposide 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 210fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Has results × gadobutrol × Clear all
NCT00375830 2023-12-12

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

Stanford University

Phase 2 Completed
114 enrolled 19 charts
Tumor-Agnostic

Neoplasms

NCT03404648 2021-02-08

Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI

Mayo Clinic

Phase 3 Completed
19 enrolled 5 charts
Genitourinary

Prostatic Neoplasms

NCT00522951 2017-08-28

SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study

Bayer

Phase 3 Completed
165 enrolled 24 charts
CNS

Brain Neoplasms

NCT01067976 2014-11-11

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI

Bayer

Phase 3 Completed
446 enrolled 30 charts
Breast

Breast Neoplasms

NCT01104584 2014-11-11

GEMMA 2

Bayer

Phase 3 Completed
460 enrolled 31 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡